The UK government must alter its current strategy for tackling covid-19 or face a further wave of infections […]
Category: Uncategorized
A GP who was suspended for forging his supervisor’s signature when he was a trainee may resume work […]
The coronavirus pandemic has exposed the vulnerability and weaknesses of already fragile global food systems, say the authors […]
Indian drugmaker Dr. Reddy’s Laboratories has had its share of run-ins with the FDA over manufacturing problems at a […]
Sanofi is touting a clinical victory that puts recently approved Sarclisa—in a regimen that also contains Amgen’s Kyprolis—on […]
Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials […]
With its megamerger with Allergan finally in the books, AbbVie is officially a colossus with a bustling drug […]
The groups will explore novel methods to characterise pluripotent stem cells for the manufacture of regenerative medicine products
The selective RET kinase inhibitor was cleared under the regulator’s accelerated approval process
The research funded will help inform policy decisions during the novel coronavirus pandemic